Inovio Pharmaceuticals, Inc. (INO)
NasdaqCM - NasdaqCM 即時價格。貨幣為 USD。
加入追蹤清單
收市：04:00PM EDT
收市後：
| 前收市價 | 11.88 |
| 開市 | 11.85 |
| 買盤 | 11.13 x 100 |
| 賣出價 | 11.24 x 100 |
| 今日波幅 | 11.01 - 11.88 |
| 52 週波幅 | 3.84 - 14.75 |
| 成交量 | |
| 平均成交量 | 467,098 |
| 市值 | 288.859M |
| Beta 值 (5 年，每月) | 1.12 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -6.09 |
| 業績公佈日 | 2024年5月13日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 19.25 |
Motley FoolThis Under-the-Radar Stock Is Up by 96% This Year: Time to Buy?
Can the biotech succeed after a string of failures?
ZacksDoes Inovio (INO) Have the Potential to Rally 122.92% as Wall Street Analysts Expect?
The consensus price target hints at a 122.9% upside potential for Inovio (INO). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Insider MonkeyInovio Pharmaceuticals, Inc. (NASDAQ:INO) Q4 2023 Earnings Call Transcript
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q4 2023 Earnings Call Transcript March 6, 2024 Inovio Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-1.12, expectations were $-1.58. Inovio Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, ladies and […]
